Computational prediction and analysis of the DR6-NAPP interaction

Proteins: Structure, Function and Bioinformatics

Volumn 79, Issue 5, 2011, Pages 1376-1395

  Ponomarev, Sergei Y ^a   Audie, Joseph ^a,b  

^a CMD Bioscience LLC   (United States)

^b SACRED HEART UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Binding free energy; Death cell receptor 6; Energy minimization; Homology modeling; Implicit solvent; N terminal amyloid precursor protein; Rigid body protein protein docking; Scoring and ranking; Structure refinement

Indexed keywords

AMYLOID PRECURSOR PROTEIN; DEATH CELL RECEPTOR 6; N TERMINAL FRAGMENT OF AMYLOID PRECURSOR PROTEIN; NEUROTROPHIN RECEPTOR P75; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BIOPHYSICS; CRYSTAL STRUCTURE; DRUG DESIGN; MOLECULAR DOCKING; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN PRECURSOR; COMPUTER SIMULATION; HUMANS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, TUMOR NECROSIS FACTOR; SEQUENCE ALIGNMENT;

RUMEX;

EID: 79954465027     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.22962     Document Type: Article

References (57)

1. Nikolaev A, McLaughlin T, O'Leary DD, Tessier-Lavigne M. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 2009; 457: 981-989.
2. Berchanski A, Lapidot A. Computer-based design of novel HIV-1 entry inhibitors: neomycin conjugated to arginine peptides at two specific sites. J Mol Model 2009; 15: 281-294.
3. Berchanski A, Lapidot A. Prediction of HIV-1 entry inhibitors neomycin-arginine conjugates interaction with the CD4-gp120 binding site by molecular modeling and multistep docking procedure. Biochim Biophys Acta 2007; 1768: 2107-2119.
4. Chapman BS, Kuntz ID. Modeled structure of the 75-kDa neurotrophin receptor. Protein Sci 1995; 4: 1696-707.
5. Litjens SH, Wilhelmsen K, de Pereda JM, Perrakis A, Sonnenberg A. Modeling and experimental validation of the binary complex of the plectin actin-binding domain and the first pair of fibronectin type III (FNIII) domains of the beta4 integrin. J Biol Chem 2005; 280: 22270-22277.
6. Nomme J, Renodon-Cornière A, Asanomi Y, Sakaguchi K, Stasiak AZ, Stasiak A, Norden B, Tran V, Takahashi M. Design of potent inhibitors of human RAD51 recombinase based on BRC motifs of BRCA2 protein: modeling and experimental validation of a chimera peptide. J Med Chem 2010; 53: 5782-5791.
7. Shamovsky IL, Ross GM, Riopelle RJ, Weaver DF. The interaction of neurotrophins with the p75NTR common neurotrophin receptor: a comprehensive molecular modeling study. Protein Sci 1999; 8: 2223-2233.
8. Walters DE, Hellekant G. Interactions of the sweet protein brazzein with the sweet taste receptor. J Agric Food Chem 2006; 54: 10129-10133.
9. Yi H, Qiu S, Cao Z, Wu Y, Li W. Molecular basis of inhibitory peptide maurotoxin recognizing Kv1.2 channel explored by ZDOCK and molecular dynamic simulations. Proteins 2008; 70: 844-854.
10. Martin OA, Villegas ME, Aguilar CF. Three-dimensional studies of pathogenic peptides from the c-terminal of Trypanosoma cruzi ribosomal P proteins and their interaction with a monoclonal antibody structural model. PMC Biophys 2009; 2: 4.
11. Lensink MF, Mendez R, Wodak SJ. Docking and scoring protein complexes: CAPRI, 3rd Edition. Proteins 2007; 69: 704-718.
12. Lensink MF, Wodak SJ. Docking and scoring protein interactions: CAPRI 2009. Proteins 2010; 78: 3073-3084.
13. Sircar A, Gray JJ. SnugDock: paratope structural optimization during antibody-antigen docking compensates for errors in antibody homology models. PLoS Comput Biol 2010; 6: e1000644.
14. Vajda S, Kozakov D. Convergence and combination of methods in protein-protein docking. Curr Opin Struct Biol 2009; 19: 164-170.
15. Halperin I, Ma B, Wolfson H, Nussinov R. Principles of docking: an overview of search algorithms and a guide to scoring functions. Proteins 2002; 47: 409-443.
16. Moitessier N, Englebienne P, Lee D, Lawandi J, Corbeil CR. Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go. Br J Pharmacol 2008; 153(Suppl 1): S7-S26.
17. Audie J. Continued development of an empirical function for predicting and rationalizing protein-protein binding affinities. Biophys Chem 2009; 143: 139-144.
18. Audie J. Development and validation of an empirical free energy function for calculating protein-protein binding free energy surfaces. Biophys Chem 2009; 139: 84-91.
19. Audie J, Scarlata S. A novel empirical free energy function that explains and predicts protein-protein binding affinities. Biophys Chem 2007; 129: 198-211.
20. Rossjohn J, Cappai R, Feil SC, Henry A, McKinstry WJ, Galatis D, Hesse L, Multhaup G, Beyreuther K, Masters CL, Parker MW. Crystal structure of the N-terminal, growth factor-like domain of Alzheimer amyloid precursor protein. Nat Struct Biol 1999; 6: 327-331.
21. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The Protein Data Bank. Nucleic Acids Res 2000; 28: 235-242.
22. He XL, Garcia KC. Structure of nerve growth factor complexed with the shared neurotrophin receptor p75. Science 2004; 304: 870-875.
23. Matrone C, Ciotti MT, Mercanti D, Marolda R, Calissano P. NGF and BDNF signaling control amyloidogenic route and Abeta production in hippocampal neurons. Proc Natl Acad Sci USA 2008; 105: 13139-13144.
24. Zhang G. Tumor necrosis factor family ligand-receptor binding. Curr Opin Struct Biol 2004; 14: 154-160.
25. Dahms SO, Hoefgen S, Roeser D, Schlott B, Gührs KH, Than ME. Structure and biochemical analysis of the heparin-induced E1 dimer of the amyloid precursor protein. Proc Natl Acad Sci USA 2010; 107: 5381-5386.
26. Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph 1996; 14: 33-38, 27-28.
27. Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 1997; 18: 2714-2723.
28. Roy A, Kucukural A, Zhang Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 2010; 5: 725-738.
29. Zhang Y. I-TASSER: fully automated protein structure prediction in CASP8. Proteins 2009; 77(Suppl 9): 100-113.
30. Zhang Y. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 2008; 9: 40.
31. Zhang Y. Template-based modeling and free modeling by I-TASSER in CASP7. Proteins 2007; 69(Suppl 8): 108-117.
32. Benkert P, Kunzli M, Schwede T. QMEAN server for protein model quality estimation. Nucleic Acids Res 2009; 37(Web Server issue): W510-W514.
33. Benkert P, Tosatto SC, Schomburg D. QMEAN: a comprehensive scoring function for model quality assessment. Proteins 2008; 71: 261-277.
34. Wiederstein M, Sippl MJ. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 2007; 35(Web Server issue): W407-W410.
35. Zhou H, Zhou Y. Distance-scaled, finite ideal-gas reference state improves structure-derived potentials of mean force for structure selection and stability prediction. Protein Sci 2002; 11: 2714-2726.
36. Alberghina L, Colangelo AM. The modular systems biology approach to investigate the control of apoptosis in Alzheimer's disease neurodegeneration. BMC Neurosci 2006; 7(Suppl 1): S2.
37. Comeau SR, Gatchell DW, Vajda S, Camacho CJ. ClusPro: a fully automated algorithm for protein-protein docking. Nucleic Acids Res 2004; 32(Web Server issue): W96-W99.
38. Comeau SR, Gatchell DW, Vajda S, Camacho CJ. ClusPro: an automated docking and discrimination method for the prediction of protein complexes. Bioinformatics 2004; 20: 45-50.
39. Bradford JR, Westhead DR. Improved prediction of protein-protein binding sites using a support vector machines approach. Bioinformatics 2005; 21: 1487-1494.
40. Comeau SR, Kozakov D, Brenke R, Shen Y, Beglov D, Vajda S. ClusPro: performance in CAPRI rounds 6-11 and the new server. Proteins 2007; 69: 781-785.
41. Comeau SR, Vajda S, Camacho CJ. Performance of the first protein docking server ClusPro in CAPRI rounds 3-5. Proteins 2005; 60: 239-244.
42. Zacharias M. Protein-protein docking with a reduced protein model accounting for side-chain flexibility. Protein Sci 2003; 12: 1271-1282.
43. Gong Y, Cao P, Yu HJ, Jiang T. Crystal structure of the neurotrophin-3 and p75NTR symmetrical complex. Nature 2008; 454: 789-793.
44. Chothia C, Lesk AM. The relation between the divergence of sequence and structure in proteins. EMBO J 1986; 5: 823-826.
45. Ring CS, Sun E, McKerrow JH, Lee GK, Rosenthal PJ, Kuntz ID, Cohen FE. Structure-based inhibitor design by using protein models for the development of antiparasitic agents. Proc Natl Acad Sci USA 1993; 90: 3583-3587.
46. Chopra G, Summa CM, Levitt M. Solvent dramatically affects protein structure refinement. Proc Natl Acad Sci USA 2008; 105: 20239-20244.
47. Summa CM, Levitt M. Near-native structure refinement using in vacuo energy minimization. Proc Natl Acad Sci USA 2007; 104: 3177-3182.
48. Summa CM, Levitt M, Degrado WF. An atomic environment potential for use in protein structure prediction. J Mol Biol 2005; 352: 986-1001.
49. Duan Y, Reddy BV, Kaznessis YN. Physicochemical and residue conservation calculations to improve the ranking of protein-protein docking solutions. Protein Sci 2005; 14: 316-328.
50. Li L, Chen R, Weng Z. RDOCK: refinement of rigid-body protein docking predictions. Proteins 2003; 53: 693-707.
51. Klima M, et al. Functional analysis of the posttranslational modifications of the death receptor 6. Biochim Biophys Acta 2009; 1793: 1579-1587.
52. Timm DE, Vissavajjhala P, Ross AH, Neet KE. Spectroscopic and chemical studies of the interactionbetween nerve growth factor (NGF) and the extracellular domain of the low affinity NGF receptor. Protein Sci 1992; 1: 1023-1031.
53. Lee D, Long SA, Adams JL, Chan G, Vaidya KS, Francis TA, Kikly K, Winkler JD, Sung CM, Debouck C, Richardson S, Levy MA, DeWolf WEJr, Keller PM, Tomaszek T, Head MS, Ryan MD, Haltiwanger RC, Liang PH, Janson CA, McDevitt PJ, Johanson K, Concha NO, Chan W, Abdel-Meguid SS, Badger AM, Lark MW, Nadeau DP, Suva LJ, Gowen M, Nuttall ME. Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality. J Biol Chem 2000; 275: 16007-16014.
54. Scheel-Toellner D, Wang K, Assi LK, Webb PR, Craddock RM, Salmon M, Lord JM. Clustering of death receptors in lipid rafts initiates neutrophil spontaneous apoptosis. Biochem Soc Trans 2004; 32(Pt 5): 679-681.
55. Goepel F, Weinmann P, Schymeinsky J, Walzog B. Identification of caspase-10 in human neutrophils and its role in spontaneous apoptosis. J Leukoc Biol 2004; 75: 836-843.
56. Kozakov D, Hall DR, Beglov D, Brenke R, Comeau SR, Shen Y, Li K, Zheng J, Vakili P, Paschalidis ICh, Vajda S. Achieving reliability and high accuracy in automated protein docking: ClusPro, PIPER, SDU, and stability analysis in CAPRI rounds 13-19. Proteins 2010; 78: 3124-3130.
57. Merz KM. Limits of free energy computation for protein-ligand interactions. J Chem Theory Comput 2010; 6: 1018-1027.